Institution: | 1. Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba Japan ; 2. Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo Japan ; 3. Department of Pathology, Chiba University Hospital, Chiba Japan ; 4. Cancer and Stem Cell Biology Program, Duke‐NUS Medical School, Singapore City Singapore |